首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献，搜索用时 46 毫秒
1.

Objective

To assess agreement between a point‐of‐care glucometer (POCG) and a laboratory chemistry analyzer for blood glucose measurements in goats.

Design

Prospective study.

Setting

University teaching hospital.

Animals

Eighteen healthy adult goats.

Investigations

Whole blood samples were obtained via jugular venipuncture prior to premedication with xylazine and butorphanol (T0), following premedication (T20), and after 1 hour of inhalant anesthesia (T60). Each sample was tested with a POCG and a laboratory analyzer (HITA). Agreement was assessed using concordance correlation coefficients and calculation of bias and 95% limits of agreement.

Measurements and Main Results

Mean blood glucose concentration at T0 was 3.9 ± 0.6 mmol/L (70 ± 10 mg/dL; POCG) and 2.9 ± 0.4 mmol/dL (53 ± 8 mg/dL; HITA). Glucose concentrations at T20 were 6.7 ± 2.4 mmol/L (121 ± 43 mg/dL) and 5.4 ± 2.1 mmol/L (97 ± 37 mg/dL) and at T60 were 5.7 ± 1.7 mmol/L (102 ± 31 mg/dL) and 4.7 ± 1.3 mmol/L (85 ± 24 mg/dL) when measured with the POCG and HITA, respectively. The POCG overestimated blood glucose compared to the HITA. The bias ± SD was 1.08 ± 0.53 mmol/L (19.4 ± 9.5 mg/dL) (95% LOA 0.04 to 2.11 mmol/L [0.7 to 38.0 mg/dL]) and the concordance correlation coefficient was 0.82. After correcting the results of the POCG using a mixed‐effects linear model, the bias was 0.0 ± 0.38 mmol/L (0.0 ± 6.8 mg/dL) (95% LOA ± 0.74 mmol/L [± 13.4 mg/dL]) and the concordance correlation coefficient was 0.98.

Conclusions

The POCG overestimated blood glucose concentrations in goats, compared to the HITA, but when the POCG concentrations were corrected, the agreement was excellent.  相似文献   

2.
A pharmacokinetic and bioavailability study of sulfadiazine combined with trimethoprim (sulfadiazine/trimethoprim) was carried out in fifteen healthy young ostriches after intravenous (i.v.), intramuscular (i.m.) and oral administration at a total dose of 30 mg/kg body weight (bw) (25 and 5 mg/kg bw of sulfadiazine and trimethoprim, respectively). The study followed a single dose, three periods, cross‐over randomized design. The sulfadiazine/trimethoprim combination was administered to ostriches after an overnight fasting on three treatment days, each separated by a 2‐week washout period. Blood samples were collected at 0 (pretreatment), 0.08, 0.25, 0.50, 1, 2, 4, 6, 8, 12, 24 and 48 h after drug administration. Following i.v. administration, the elimination half‐life (t1/2β), the mean residence time (MRT), volume of distribution at steady‐state (Vd(ss)), volume of distribution based on terminal phase (Vd(z)), and the total body clearance (ClB) were (13.23 ± 2.24 and 1.95 ± 0.19 h), (10.06 ± 0.33 and 2.17 ± 0.20 h), (0.60 ± 0.08, and 2.35 ± 0.14 L/kg), (0.79 ± 0.12 and 2.49 ± 0.14 L/kg) and (0.69 ± 0.03 and 16.12 ± 1.38 mL/min/kg), for sulfadiazine and trimethoprim, respectively. No significant difference in Cmax (35.47 ± 2.52 and 37.50 ± 3.39 μg/mL), tmax (2.47 ± 0.31 and 2.47 ± 0.36 h), t½β (11.79 ± 0.79 and 10.96 ± 0.56 h), Vd(z)/F (0.77 ± 0.06 and 0.89 ± 0.07 L/kg), ClB/F (0.76 ± 0.04 and 0.89 ± 0.07) and MRT (12.39 ± 0.40 and 12.08 ± 0.36 h) were found in sulfadiazine after i.m. and oral dosing, respectively. There were also no differences in Cmax (0.71 ± 0.06 and 0.78 ± 0.10 μg/mL), tmax (2.07 ± 0.28 and 3.27 ± 0.28 h), t½β (3.30 ± 0.25 and 3.83 ± 0.33 h), Vd(z)/F (6.2 ± 0.56 and 6.27 ± 0.77 L/kg), ClB/F (21.9 ± 1.46 and 18.83 ± 1.72) and MRT (3.68 ± 0.19 and 4.34 ± 0.14 h) for trimethoprim after i.m. and oral dosing, respectively. The absolute bioavailability (F) was 95.41% and 86.20% for sulfadiazine and 70.02% and 79.58% for trimethoprim after i.m. and oral administration, respectively.  相似文献   

3.
1. A study was conducted to compare apparent and true digestibility of amino acids in a high protein experimental diet between young ostriches (7 months of age) and cockerels.

2. A mean value for true digestibility of amino acids (TAAD) of 0.837 ± 0.0073 (range 0.780 to 0.862) was derived for ostriches, compared with a mean value of 0.795 ± 0.0258 (range 0.723 to 0.825) for cockerels.

3. True retention of dietary protein was 0.646 ±0.0114 and 0.609 ±0.0643 for ostriches and cockerels respectively.

4. Results in the present study produced evidence that the method for determining metabolisable energy values of ingredients for ostriches is also suitable for measuring the digestibility of amino acids.

5. It was concluded that accurate diet formulation for ostriches requires the assessment of amino acid digestibilities for individual ingredients, because values derived from poultry would underestimate digestibilities for ostriches.  相似文献   


4.
  相似文献   

5.
Pharmacokinetic parameters of oxytetracycline were analysed in healthy preruminant veal calves after intravenous, intramuscular and oral administration. The serum half-lives in the β-elimination phase of both 10% and 20% solutions after i.v. injection of 10 mg/kg were similar (7.07 ± 1.36 h and 7.16 ± 1.17 h, mean ± SD), whereas the total body clearance and the apparent volume of distribution were higher for the 20% solution. Serum concentrations above 0.5 μg/ml were maintained with both formulations during 12–24 h but were only above 4 μg/ml to 5 h. Intramuscular administration of the 20% solution gave a complete absorption with two rate constants of absorption, a faster (t1/2a1= 0.27 h) and a slower one (t1/2a2= 10.90 h) responsible for the delayed elimination half-life after this route of application (t1/2β= 9.83 ± 1.35 h). Mean serum concentrations reached a maximum level of 3.01 ± 0.72 μg/ml at 4.01 ± 2.84 h and decreased to 0.5 μg/ml between 12 and 24 h. 50 mg/kg given orally with a milk replacer were found to have a mean bioavailability of 46.35%. A mean serum peak level of 4.99 ± 1.37 μg/ml was achieved at 9.16 ± 1.99 h and the mean concentration was still above 0.5 μg/ml after 48 h. The elimination half-life (t1/2β= 10.66 ± 3.15 h) reflected the slow absorption step (t1/2a2= 10.15 h) following that responsible for the initial faster absorption (t1/2a2= 1.99 h). Comparison of the area under the serum curves gave mean values of 117% for tetracycline and of 53% for chlortetracycline relative to oxytetracycline (arbitrarily fixed at 100%) after identical oral dosage of the three tetracyclines. We also propose and discuss a dosage schedule based on minimal inhibitory concentrations of different susceptible pathogens  相似文献   

6.
A study with the objectives of estimating breed differences, heterosis and recombination effects as well as heritabilities (h2) and repeatabilities (r2) for age at first calving (AFC), calving interval (CI), days open (DO) and number of services per conception (SPC) was conducted using reproduction records collected from 1496 cows comprising purebred Boran (B), Friesian (F), crosses of Friesian and Jersey (J) with Boran breeds. The crossbred cow groups included four F × B crosses [1/2F:1/2B(F1), 1/2F:1/2B(F2), 5/8F:3/8B and 3/4F:1/4B], three J × B crosses [1/2J:1/2B(F1), 1/2J:1/2B(F2) and 3/4J:1/4B] and one three‐breed cross (1/4F:1/4J:1/2B). The crossbreeding parameters were estimated using a repeatability animal model for CI, DO and SPC, and a unitrait animal model for AFC. The overall least‐squares means estimated were: 38.3 ± 0.26 months, 435 ± 4 days, 145 ± 10 days and 1.58 ± 0.03 (number) for AFC, CI, DO and SPC, respectively. The breed additive effects of F and J were only significant (p < 0.01) for AFC. Relative to B, both F and J additive contributions for AFC were ?5.4 ± 0.5 and ?5.5 ± 1.9 months, respectively. Crossing the B with F and J breeds also resulted in significant heterosis (p < 0.05) ranging from 10 to 21% in all traits. The estimated recombination loss was only significant for AFC (2.8 ± 1.0 months) for F × B crosses. Heritability estimates were high for AFC (0.44 ± 0.05) and low for CI (0.08 ± 0.03), DO (0.04 ± 0.03) and SPC (0.08 ± 0.02). The corresponding estimates for the repeatability (r2) were 0.14 ± 0.02 and 0.14 ± 0.02 for CI and DO, respectively. The permanent environmental effect for SPC was zero. These findings show that breed differences between F or J and B, and the individual cow variations are low for reproductive traits studied, except for AFC. Heterotic effects seem to be the major genetic causes for the improved reproductive performances in both the F × B and J × B crossbred cows.  相似文献   

7.

Objective

To compare the induction and recovery characteristics and selected cardiopulmonary variables of midazolam–alfaxalone or midazolam–ketamine in donkeys sedated with xylazine.

Study design

Randomized, blinded, crossover experimental trial.

Animals

A group of seven adult male castrated donkeys weighing 164 ± 14 kg.

Methods

Donkeys were randomly administered midazolam (0.05 mg kg?1) and alfaxalone (1 mg kg?1) or midazolam (0.05 mg kg?1) and ketamine (2.2 mg kg?1) intravenously following sedation with xylazine, with ≥ 7 days between treatments. Donkeys were not endotracheally intubated and breathed room air. Time to lateral recumbency, first movement, sternal recumbency and standing were recorded. Induction and recovery were assigned scores between 1 (very poor) and 5 (excellent). Heart rate (HR), respiratory rate (fR), invasive arterial blood pressures and arterial blood gases were measured before induction and every 5 minutes following induction until first movement.

Results

Time to lateral recumbency (mean ± standard deviation) was shorter after alfaxalone (29 ± 10 seconds) compared with ketamine (51 ± 9 seconds; p = 0.01). Time to first movement was the same between treatments (27 versus 23 minutes). Time to standing was longer with alfaxalone (58 ± 15 minutes) compared with ketamine (33 ± 8 minutes; p = 0.01). Recovery score [median (range)] was of lower quality with alfaxalone [3 (2–5)] compared with ketamine [5 (3–5); p = 0.03]. There were no differences in HR, fR or arterial pressures between treatments. No clinically important differences in blood gases were identified between treatments. Five of seven donkeys administered alfaxalone became hypoxemic (PaO2 <60 mmHg; 8.0 kPa) and all donkeys administered ketamine became hypoxemic (p = 0.13).

Conclusions and clinical relevance

Both midazolam–alfaxalone and midazolam–ketamine produced acceptable anesthetic induction and recovery in donkeys after xylazine sedation. Hypoxemia occurred with both treatments.  相似文献   

8.
The effects of maturation on the intravenous (IV) and intramuscular (IM) pharmacokinetics of ceftiofur sodium following a dose of 2.2 mg ceftiofur equivalents/kg body weight were evaluated in 16 one-day-old Holstein bull calves (33-53 kg body weight initially; Group 1) and 14 six-month-old Holstein steers (217-276 kg body weight initially; Group 2). Group 1 calves were fed unmedicated milk replacer until 30 days of age and were then converted to the same roughage/concentrate diet as Group 2. Groups 1-IV and 2-IV received ceftiofur sodium IV, and Groups 1-IM and 2-IM received ceftiofur sodium IM. Group 1 calves were dosed at 7 days of age and at 1 and 3 months of age; group 2 calves were dosed at 6 and 9 months of age. Blood samples were obtained serially from each calf, and plasma samples were analysed using an HPLC assay that converts ceftiofur and all desfuroylceftiofur metabolites to desfuroylceftiofur acetamide. Cmax values were similar in all calves, and were no higher in younger calves than in older calves. Plasma concentrations remained above 0.150 μg ceftiofur free acid equivalents/mL for 72 h in 7-day-old calves, but were less than 0.150 μg/mL within 48 h following IV or IM injection for 6- and 9-month-old calves. Intramuscular bioavailability, assessed by comparing the model-derived area under the curve (AUCmod) from IM and IV injection at each age, appeared to be complete. After IV administration, the AUCmod in 7-day-old and 1-month-old calves (126.92±21.1 μg-h/mL and 135.0±21.6 μg.h/mL, respectively) was significantly larger than in 3-, 6- and 9-month-old calves (74.0±10.7 μg.h/mL, 61.0±17.7 μg.h/mL and 68.5±12.8 μg.h/mL, respectively; P< 0.0001). The Vd(ss) decreased linearly within the first 3 months of life in cattle (0.345±0.0616 L/kg, 0.335±0.919 L/kg and 0.284±0.0490 L/kg, respectively; P= 0.031), indicative of the decreasing extracellular fluid volume in maturing cattle. The Clb was significantly smaller in 7-day-old and 1-month-old calves (0.0178±0.00325 L/h.kg and 0.0167±0.00310 L/h.kg, respectively) than in 3-, 6- and 9-month-old calves (0.0303±0.0046 L/h.kg, 0.0398±0.0149 L/h.kg and 0.0330±0.00552 L/h.kg, respectively; P≦0.001). This observation may be indicative of maturation of the metabolism and/or excretion processes for ceftiofur and desfuroylceftiofur metabolites. The approved dosage regimens for ceftiofur sodium of 1.1-2.2 mg/kg administered once daily for up to 5 consecutive days will provide plasma concentrations above the MIC for bovine respiratory disease pathogens for a longer period of time in neonatal calves than in older calves. Peak plasma concentrations of ceftiofur and desfuroylceftiofur metabolites were no higher in neonatal calves than in more mature cattle, highly suggestive that peak tissue concentrations would be no higher in neonatal calves than in more mature cattle.  相似文献   

9.
ObjectiveTo investigate physiological and sedative/immobilization effects of medetomidine or dexmedetomidine combined with ketamine in free-ranging Chinese water deer (CWD).Study designProspective clinical trial.Animals10 free-ranging adult Chinese water deer (11.0 ± 2.6 kg).MethodsAnimals were darted intramuscularly with 0.08 ± 0.004 mg kg?1 medetomidine and 3.2 ± 0.2 mg kg?1 ketamine (MK) or 0.04 ± 0.01 mg kg?1 dexmedetomidine and 2.9 ± 0.1 mg kg?1 ketamine (DMK) If the animal was still laterally recumbent after 60 minutes of immobilization, atipamezole was administered intravenously (MK: 0.4 ± 0.02 mg kg?1, DMK: 0.2 ± 0.03 mg kg?1). Heart rate (HR) respiratory rate (fR) and temperature were recorded at 5-minute intervals. Arterial blood was taken 15 and 45 minutes after initial injection. Statistical analysis was performed using Student’s t-test or anova. p < 0.05 was considered significant.ResultsAnimals became recumbent rapidly in both groups. Most had involuntary ear twitches, but there was no response to external stimuli. There were no statistical differences in mean HR (MK: 75 ± 14 beats minute?1; DMK: 85 ± 21 beats minute?1), fR (MK: 51 ± 35 breaths minute?1; DMK; 36 ± 9 breaths minute?1), temperature (MK: 38.1 ± 0.7 °C; DMK: 38.4 ± 0.5 °C), blood gas values (MK: PaO2 63 ± 6 mmHg, PaCO2 49.6 ± 2.6 mmHg, HCO3? 30.8 ± 4.5 mmol L?1; DMK: PaO2 77 ± 35 mmHg, PaCO2 45.9 ± 11.5 mmHg, HCO3? 31.0 ± 4.5 mmol L?1) and biochemical values between groups but temperature decreased in both groups. All animals needed antagonism of immobilization after 60 minutes. Recovery was quick and uneventful. There were no adverse effects after recovery.Conclusion and clinical relevanceBoth anaesthetic protocols provided satisfactory immobilisation. There was no clear preference for either protocol and both appear suitable for CWD.  相似文献   

10.
Fifteen male Murrah buffalo calves (15–18 months, 227.98?±?4.44 kg body weight) were distributed randomly in to three equal groups and fed solely on either berseem (G1), oats (G2), or chicory fodder (G3). A digestibility trial followed by methane measurement using SF6 tracer technique was conducted. No significant difference was observed in nutrient intake; however, crude protein (CP) intake was lower in G2 (0.35 kg) than G1 (0.7) and in G3 (0.71) and non-fibrous carbohydrates (NFC), and neutral detergent insoluble CP (NDICP) intake was significantly (p?<?0.05) higher in G3 (1.54 and 0.31 kg) followed by G2 (1.27 and 0.2 kg) and G1 (1.06 and 0.18 kg). The digestible dry matter, organic matter, neutral detergent fiber, and ether extract intake was similar in all the groups, whereas the digestible CP and NFC intake was lower in G2 compared to G1 and G3. Chicory- and berseem-fed groups emitted 12.2 and 5.2 % less methane than oats-fed group. However, no significant difference was observed in the absolute methane loss and methane loss as percentage of energy intake (p?>?0.05) among the groups. There was positive correlation between nutrient intake and total methane production. However, an inverse relationship was observed between total digestible carbohydrate intake and methane production (g/kg dry matter intake). The following regression equations were developed to estimate methane production: methane (g/kg BW) = 128.8553 + (167.7456 × dNDFI) + (216.32 × dCPI) ? (40.3313 × dNFCI) and methane (g/d) = ?1.7494 + (41.42 × NDFI) + (39.8686 × CPI) + (0.5197 × NFCI).  相似文献   

11.
1. Over three breeding seasons on a farm in Poland, semen was collected from 11 ostriches using the dummy and the teaser method to study the effects of the method of collection, male age, month in the breeding season, and daily collection frequency on ejaculate characteristics.

2. A total of 259 ejaculates were collected, with an average volume of 1·28?±?0·6 (±SEM) ml. Sperm concentration was 3·34?±?0·08?×?109/ml, the total number of spermatozoa 4·32?±?0·22?×?109, and motility 4·56?±?0·04.

3. There was no difference in ejaculates collected by the dummy and teaser methods, but the between-individual variation was considerable. Ejaculate characteristics increased with male age and varied between months, with little evidence for seasonal decline. Daily collections for 10 days did not affect sperm output.

4. The results open up avenues for further research on development of a viable protocol for artificial insemination in ostriches and efficient semen storage.

5. The between-male variation suggests that the ejaculate output could be maximized through selection.  相似文献   

12.
Background: The efficacy of intravenous (IV) administration of azumolene (Az), an analogue 30‐fold more soluble than dantrolene, on pigs susceptible to malignant hyperthermia (MH) is incompletely understood. Objective: To evaluate efficacy of Az on MH crisis in pigs. Animals: Eight normal (MHN) and 7 susceptible to MH (MHS) pigs (Landrace × Large White × Pietran). Methods: Prospective, laboratory trial. Hypermetabolic crisis was observed in MHS pigs, but not in MHN pigs, after a combined administration of inhaled halothane (1.5%) and IV injection of succinylcholine (SCh; 2.5 mg/kg). Susceptibility was confirmed using a caffeine and halothane contracture test. Az was administered 15 minutes after administration of SCh. Results: Respiratory acidosis (pH 7.16 ± 0.02; Pco 2, 46.2 ± 9.1 mmHg, HCO3, 22.5 ± 2.3 mmol/L), fever (38.2 ± 1.1°C), cardiac arrhythmias, and muscle contracture were observed in MHS pigs. MHS pigs (n = 5) treated with Az (2 mg/kg IV) survived the crisis with attenuation of signs (pH 7.30 ± 0.10; Pco 2, 36.3 ± 4.5 mmHg; HCO3, 22.9 ± 2.3 mmol/L) and recovery of normal muscle tone and cardiac rhythm. Conclusions and Clinical Importance: Az represents a possible substitute for dantrolene to reverse MH crisis in susceptible pigs.  相似文献   

13.

Objective

To determine the effect of fentanyl on the induction dose and minimum infusion rate of alfaxalone required to prevent movement in response to a noxious stimulus (MIRNM) in dogs.

Study design

Experimental crossover design.

Animals

A group of six healthy, adult, intact female mixed-breed dogs, weighing 19.7 ± 1.3 kg.

Methods

Dogs were randomly administered one of three treatments at weekly intervals: premedication with 0.9% saline (treatment A), fentanyl 5 μg kg–1 (treatment ALF) or fentanyl 10 μg kg–1 (treatment AHF), administered intravenously over 5 minutes. Anesthesia was induced 5 minutes later with incremental doses of alfaxalone to achieve intubation and was maintained for 90 minutes in A with alfaxalone (0.12 mg kg–1 minute–1), in ALF with alfaxalone (0.09 mg kg–1 minute–1) and fentanyl (0.1 μg kg–1 minute–1) and in AHF with alfaxalone (0.06 mg kg–1 minute–1) and fentanyl (0.2 μg kg–1 minute–1). The alfaxalone infusion was increased or decreased by 0.006 mg kg–1 minute–1 based on positive or negative response to antebrachium stimulation (50 V, 50 Hz, 10 ms). Data were analyzed using a mixed-model anova and presented as least squares means ± standard error.

Results

Alfaxalone induction doses were 3.50 ± 0.13 (A), 2.17 ± 0.10 (ALF) and 1.67 ± 0.10 mg kg–1 (AHF) and differed among treatments (p < 0.05). Alfaxalone MIRNM was 0.17 ± 0.01 (A), 0.10 ± 0.01 (ALF) and 0.07 ± 0.01 mg kg–1 minute–1 (AHF) and differed among treatments. ALF and AHF decreased the MIRNM by 44 ± 8% and 62 ± 5%, respectively (p < 0.05). Plasma alfaxalone concentrations at MIRNM were 5.82 ± 0.48 (A), 4.40 ± 0.34 (ALF) and 2.28 ± 0.09 μg mL–1 (AHF).

Conclusions and clinical relevance

Fentanyl, at the doses studied, significantly decreased the alfaxalone induction dose and MIRNM.  相似文献   

14.
The biopharmaceutical properties of four fuced trimethoprim/sulfonamide combinations were investigated in the horse. Eight fasted horses were dosed at 1 week intervals in a sequentially designed study with one intravenous (i.v.) and three oral trimethoprim/sulfadiazine (TMP/SDZ) formulations (1, 2 and 3) administered at a dose of 5 mg/kg trimethoprim (TMP) and 25 mg/kg sulfadiazine (SDZ). Plasma concentrations of each compound were monitored for 48 h. Pharmacokinetic parameters (volume of distribution, bioavailability and total body clearance) for TMP and SDZ were calculated and compared. After oral administration plasma concentrations of TMP and SDZ increased rapidly. With all three paste formulations, TMP peak plasma concentrations were attained within 2 h. SDZ mean peak plasma concentrations were reached at 2.59 ± 0.48 h for a commercial paste (l), and at 1.84 ± 0.66 h and 1.95 ± 0.61 h for the two self-made formulations (2 and 3). Mean peak plasma TMP concentrations (± SD) were 1.72 ± 0.36 μg/ml, 1.42 ± 0.37 μg/ml and 1.31 ± 0.36 μ g/d, and mean peak plasma SDZ concentrations 12.11 ± 4.5 5 μg/ml, 12.72 ± 3.47 μg/ml and 15.45 ± 4.74 μg/ml for preparations 1, 2 and 3. The bioavailability of TMP was 67.0 ± 20.3%, 57.7 ±21.6% and 60.9 f 18.9% and of SDZ 57.6 ± 14.8%, 59.3 ± 19.5% and 65.9 ± 5.8% for SDZ for 1, 2 and 3, respectively. Following i.v. administration TMP/SDZ plasma concentration ratios approached the optimal 1:20 ratio (It 10%) for about 5 h, but following the oral administrations this ratio was only achieved for a very short time-span. No adverse effects were seen following i.v. and oral administration. In considering the pharmacokinetic data in combination with in vitro antibacterial sensitivity data, it is concluded that treatment at a dose of 5 mg/kg TMP and 25 mg/kg SDZ with a dosing interval of 12 h can be regarded as therapeutically effective for susceptible bacteria (MIC90 0.25/4.75) for all three oral formulations. It is concluded that neither the formulation nor the addition of different excipients result in significantly different bioavailabilities.  相似文献   

15.

Objective

To evaluate motor and sensory blockade of combining dexmedetomidine with ropivacaine, administered perineurally or systemically, for femoral and sciatic nerve blocks in conscious dogs.

Study design

Randomized, controlled, experimental study.

Animals

Seven healthy Beagle dogs, aged 3.3 ± 0.1 years and weighing 11.0 ± 2.4 kg.

Methods

Dogs were anesthetized with isoflurane on three separate occasions for unilateral femoral and sciatic nerve blocks and were administered the following treatments in random order: perineural ropivacaine 0.75% (0.1 mL kg–1) on each nerve and intramuscular (IM) saline (0.2 mL kg–1) (GCON); perineural dexmedetomidine (1 μg mL–1) and ropivacaine 0.75% (0.1 mL kg–1) on each nerve and IM saline (0.2 mL kg–1) (GDPN); and perineural ropivacaine 0.75% (0.1 mL kg–1) on each nerve and IM dexmedetomidine (1 μg mL–1, 0.2 mL kg–1) (GDIM). Nerve blocks were guided by ultrasound and electrical stimulation and dogs were allowed to recover from general anesthesia. Sensory blockade was evaluated by response to clamp pressure on the skin innervated by the saphenous/ femoral, common fibular and tibial nerves. Motor blockade was evaluated by observing the ability to walk and proprioception. Sensory and motor blockade were evaluated until their full recovery.

Results

No significant differences in onset time to motor and sensory blockade were observed among treatments. Duration of motor blockade was not significantly different among treatments; however, duration of tibial sensory blockade was longer in the GDPN than in the GDIM treatment.

Conclusions and clinical relevance

Although a longer duration of sensory blockade was observed with perineural dexmedetomidine, a significant increase compared with the control group was not established. Other concentrations should be investigated to verify if dexmedetomidine is a useful adjuvant to local anesthetics in peripheral nerve blocks in dogs.  相似文献   

16.
The purpose of this study was to determine an oral dosing regimen of zonisamide in healthy dogs such that therapeutic concentrations would be safely reached and maintained at steady‐state. Adult hound dogs (n = 8) received a single IV (6.9) and an oral (PO) dose (10.3 mg/kg) using a randomized cross‐over design. Zonisamide was then administered at 10.3 mg/kg PO every 12 h for 8 weeks. Zonisamide was quantitated in blood compartments or urine by HPLC and data were subjected to noncompartmental pharmacokinetic analysis. Comparisons were made among blood compartments (one‐way anova ; P ≤ 0.05). Differences among blood compartments occurred in all derived pharmacokinetic paramenters for each route of administration after single and multiple dosing. After single PO dosing, plasma Cmax was 14.4 ± 2.3 mcg/mL and elimination half‐life was 17.2 ± 3.6 h. After IV dosing, volume of distribution was 1.1 ± 0.25 L/kg, clearance was 58 ± 11 mL/h/kg and elimination t1/2 was 12.9 ± 3.6 h. Oral bioavailability was 68 ± 12%; fraction of unbound drug approximated 60%. At steady‐state (4 days), differences occurred for for all parameters except Cmax and Cmin. Plasma Cmax at steady‐state was 56 ± 12 mcg/mL, with 10% fluctuation between Cmax and Cmin. Plasma t1/2 (h) was 23.52 ± 5.76 h. Clinical laboratory tests remained normal, with the exception of total T4, which was below normal limits at study end. In conclusion, 10 mg/kg twice daily results in peak plasma zonisamide which exceeds the recommended human therapeutic range (10 to 40 μg/mL) and is associated with suppression of thyroid hormone synthesis. A reasonable b.i.d starting dose for canine epileptics would be 3 mg/kg. Zonisamide monitored in either serum or plasma should be implemented at approximately 7 days.  相似文献   

17.
1. A pharmacokinetic study of valnemulin was conducted in healthy Muscovy ducks after intravenous (IV), intramuscular (IM) and oral administrations at a dose rate of 15?mg/kg body weight.

2. Drug concentrations in plasma were determined by high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS). Pharmacokinetics parameters of valnemulin were analysed by compartmental analysis using the WinNonlin program.

3. After IV administration, valnemulin was widely distributed with a volume of distribution based on a terminal phase (Vz) of 8·19?±?3·07?l/kg, a mean elimination half-life (t1/2Ke) of 2·63?h, and a clearance (Cl) value of 5·56?±?1·53?l/kg/h. Following intramuscular and oral administration, valnemulin was rapidly absorbed; the Cmax was 0·44?±?0·13 and 0·12?±?0·02?µg/ml (achieved at 0·28 and 1·80?h), the t1/2Ke was 3·17?±?3·83 and 4·83?±?1·81?h, and the absolute bioavailability (F) was 72% and 37%, respectively.

4. The plasma profile of valnemulin exhibited favourable pharmacokinetic characteristics in Muscovy ducks, such as wide distribution, and rapid absorption and elimination, though oral bioavailability was low.  相似文献   

18.
Glycogen synthesis by mink uterine glandular and luminal epithelia (GE and LE) is stimulated by estradiol (E2) during estrus. Subsequently, the glycogen deposits are mobilized to near completion to meet the energy requirements of pre‐embryonic development and implantation by as yet undetermined mechanisms. We hypothesized that progesterone (P4) was responsible for catabolism of uterine glycogen reserves as one of its actions to ensure reproductive success. Mink were treated with E2, P4 or vehicle (controls) for 3 days and uteri collected 24 h (E2, P4 and vehicle) and 96 h (E2) later. To evaluate E2 priming, mink were treated with E2 for 3 days, then P4 for an additional 3 days (E2→P4) and uteri collected 24 h later. Percent glycogen content of uterine epithelia was greater at E2 + 96 h (GE = 5.71 ± 0.55; LE = 11.54 ± 2.32) than E2+24 h (GE = 3.63 ± 0.71; LE = 2.82 ± 1.03), and both were higher than controls (GE = 0.27 ± 0.15; LE = 0.54 ± 0.30; P < 0.05). Treatment as E2→P4 reduced glycogen content (GE = 0.61 ± 0.16; LE = 0.51 ± 0.13), to levels not different from controls, while concomitantly increasing catabolic enzyme (glycogen phosphorylase m and glucose‐6‐phosphatase) gene expression and amount of phospho‐glycogen synthase protein (inactive) in uterine homogenates. Interestingly, E2→P4 increased glycogen synthase 1 messenger RNA (mRNA) and hexokinase 1mRNA and protein. Our findings suggest to us that while E2 promotes glycogen accumulation by the mink uterus during estrus and pregnancy, it is P4 that induces uterine glycogen catabolism, releasing the glucose that is essential to support pre‐embryonic survival and implantation.  相似文献   

19.

Objective

To compare time to desaturation after induction of anesthesia following administration of oxygen via face mask or flow-by for 3 minutes.

Study design

Randomized crossover study.

Animals

A group of six healthy adult dogs weighing 15.0 ± 3.4 kg.

Methods

Dogs were anesthetized twice separated by 14 days. Intramuscular administration of dexmedetomidine (4 μg kg?1), acepromazine (0.01 mg kg?1) and butorphanol (0.2 mg kg?1) provided sedation for percutaneous insertion of a catheter into the tracheal lumen. The tip was advanced to the thoracic inlet and position confirmed using fluoroscopy. Using a sample aspiration rate 200 mL minute?1, inspired (FIO2) and end-tidal oxygen (Fe′O2) were measured. Oxygen (100 mL kg?1 minute?1) was delivered into a circle delivery system and administered to the dog for 3 minutes via face mask or flow-by from the circle Y-piece 2.5 cm from the nares. Then, propofol was administered to induce anesthesia and apnea. A pulse oximeter (lingual probe) measured hemoglobin saturation (SpO2). At SpO2 90% (desaturation point), an endotracheal tube was inserted to allow administration of oxygen and artificial ventilation. Arterial blood and data were collected at baseline (before oxygen administration), 5 seconds after induction of anesthesia, and every 30 seconds until the desaturation point was reached. Data were analyzed using an unpaired and paired t test with (p < 0.05).

Results

FIO2, Fe′O2 and PaO2 (mean ± standard deviation) were significantly higher after mask preoxygenation [89.7 ± 5.5%, 83.0 ± 7.6% and 394 ± 112 mmHg (52.4 ± 14.9 kPa)] compared with flow-by [30.0 ± 5.4%, 22.7 ± 3.8% and 133 ± 22 mmHg (17.7 ± 2.9 kPa)], respectively. Time to desaturation was significantly longer after mask treatment compared with flow-by (187 ± 67 versus 66 ± 17 seconds).

Conclusions and clinical relevance

Mask preoxygenation provided longer time to desaturation compared with the flow-by technique tested.  相似文献   

20.
The aims of this study were (i) to describe the changes in the volume of large ovarian follicles (diameter >3 cm) during the 48 h egg laying cycle in farmed ostriches, and (ii) to quantify factors affecting the volume of the largest measured follicle and the plasma concentrations of progesterone (P4) and estradiol‐17β (E2β). In eight egg‐producing birds, which all ovulated during the study period, transcutaneous ultrasound scanning and blood sampling was performed at 3 h intervals. The average volume of the total number of visualized large follicles (Vtotal), the largest measured follicle (VF1), the second largest follicle (VF2) and of all follicles smaller than F2 (VF3–Fn) were each higher before than after oviposition. Vtotal, VF2 and VF3–Fn nearly doubled in the 24‐h period before oviposition, while VF1 remained at an equal, rather high level until oviposition. Immediately after oviposition Vtotal, as well as the volume of the other follicle categories, decreased within 6 h, i.e. around the moment of ovulation. By performing statistical analysis on the basis of linear mixed‐effects modelling, we quantified that: (i) VF1 was 13.2% higher before than after oviposition and increased with 6.5% when LH increased with 1 ng/ml; (ii) P4 levels were 93.2% higher before than after oviposition and increased with 43.1% for every 3 h closer to oviposition; when LH and E2β levels and VF1 increased with 1 ng/ml, 10 pg/ml and 10 ml, respectively, P4 increased with 116.6%, 50% and 6.1%; and (iii) E2β levels were 35.6% higher before than after oviposition, increased with 2.7% for every 3 h closer to oviposition and increased with 14.6% when LH increased with 1 ng/ml. It is concluded that during the egg‐laying cycle in ostriches: (i) follicular mass, as estimated by the volume of visualized follicles larger than 3 cm, increases before and decreases after ovulation, and (ii) follicular dynamics and its accompanying endocrine plasma hormone profiles during the egg‐laying cycle in ostriches follow a pattern similar to that in chickens.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号